The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing FOLR1 expression in low-grade serous ovarian carcinoma.
 
Tullia Rushton
No Relationships to Disclose
 
Harris Benjamin Krause
Employment - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
Anthony Karnezis
Research Funding - Fate Therapeutics
 
Michael Driscoll Toboni
No Relationships to Disclose
 
Premal H. Thaker
Stock and Other Ownership Interests - Immunon
Consulting or Advisory Role - AADi; AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; Immunon; Iovance Biotherapeutics; Merck; Novocure; R-Pharm; Seagen; Verastem/Pharmacyclics; Zentalis
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
 
David R. Braxton
Stock and Other Ownership Interests - Precidx corp
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Amgen; Janssen Oncology; QED Therapeutics
Research Funding - Deep Lens; Imagene AI; Tizona Therapeutics, Inc.
Travel, Accommodations, Expenses - Caris Life Sciences
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
David Marc Gershenson
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson; Procter & Gamble
Consulting or Advisory Role - AADi; Genentech; Onconova Therapeutics; SpringWorks Therapeutics; Verastem
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Elsevier as book editor; Royalties from UpToDate for authorship
 
Deborah Kay Armstrong
Consulting or Advisory Role - Johnson & Johnson/Janssen; Teon Therapeutics
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Pfizer (Inst); Syndax (Inst)
Other Relationship - AstraZeneca; AstraZeneca; AstraZeneca